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Abstract
The enzymatic activity of the type 2A protein phosphatase (PP2A) holoenzyme, a major serine/threonine phosphatase in the
heart, is conferred by its catalytic subunit (PP2AC). PP2AC activity and subcellular localisation can be regulated by reversible
carboxylmethylation of its C-terminal leucine309 (leu309) residue. Previous studies have shown that the stimulation of
adenosine type 1 receptors (A1.Rs) induces PP2AC carboxylmethylation and altered subcellular distribution in adult rat
ventricular myocytes (ARVM). In the current study, we show that the enzymatic components that regulate the
carboxylmethylation status of PP2AC, leucine carboxylmethyltransferase-1 (LCMT-1) and phosphatase methylesterase-1
(PME-1) are abundantly expressed in, and almost entirely localised in the cytoplasm of ARVM. The stimulation of Gi-coupled
A1.Rs with N6-cyclopentyladenosine (CPA), and of other Gi-coupled receptors such as muscarinic M2 receptors (stimulated
with carbachol) and angiotensin II AT2 receptors (stimulated with CGP42112) in ARVM, induced PP2AC carboxylmethylation
at leu309 in a concentration-dependent manner. Exposure of ARVM to 10 mM CPA increased the cellular association
between PP2AC and its methyltransferase LCMT-1, but not its esterase PME-1. Stimulation of A1.Rs with 10 mM CPA
increased the phosphorylation of protein kinase B at ser473, which was abolished by the PI3K inhibitor LY294002 (20 mM),
thereby confirming that PI3K activity is upregulated in response to A1.R stimulation by CPA in ARVM. A1.R-induced PP2AC
translocation to the particulate fraction was abrogated by adenoviral expression of the alpha subunit (Gat1) coupled to the
transducin G-protein coupled receptor. A similar inhibitory effect on A1.R-induced PP2AC translocation was also seen with
LY294002 (20 mM). These data suggest that in ARVM, A1.R-induced PP2AC translocation to the particulate fraction occurs
through a GiPCR-Gbc-PI3K mediated intracellular signalling pathway, which may involve elevated PP2AC carboxylmethyla-
tion at leu309.
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Introduction
The type 2A protein phosphatase (PP2A) is a serine/threonine
protein phosphatase that is ubiquitously expressed in all eukaryotic
cells and may account for up to 1% of total cellular protein [1]. A
significant proportion (,30%) of PP2A consists as a scaffold (A)
subunit complexed with the catalytic (C) subunit to form PP2AA/C
heterodimers [2]. The PP2AA/C heterodimer subunits provide a
platform for the binding of a third component, the regulatory B
subunit, which facilitates ‘‘targeting’’ of the heterotrimeric
holoenzyme towards target substrates [3].
The PP2A catalytic subunit undergoes reversible post-transla-
tional phosphorylation and carboxylmethylation, both of which
can alter catalytic activity and cellular distribution of PP2A.
Phosphorylation of threonine304 and tyrosine307 residues in the
carboxyl terminus of the protein is associated with inhibition of
PP2AC activity [4,5]. Carboxylmethylation of PP2AC occurs at the
C-terminal leucine309 (leu309) and is catalysed by leucine
carboxylmethyltransferase-1 (LCMT-1), a member of a large
methyltransferase family of enzymes that utilise S-adenosyl
methionine (SAM/AdoMet) as a universal methyl donor [6].
The carboxylmethylation of leu309 increases the binding affinity
of the PP2AA/C heterodimer for some, but not all, regulatory B
subunits, which have been classified into four separate sub families
and are encoded by 15 human genes: PPP2R2/B (A–D), PPP2R5/
B9 (A–E), PPP2R3/B0 (A–C) and the striatins/B90 (1, 3 and 4).
Through alternative gene splicing, several of these genes can
generate a number of splice variants, resulting in the expression of
20+ regulatory B subunits [7]. The importance of PP2AC leu309
carboxylmethylation by LCMT-1 for recruitment of regulatory B
subunits to the PP2AA/C heterodimer can be considered a sliding
scale, whereby it is an absolute prerequisite for PPP2R2/B subunit
recruitment by the PP2AA/C heterodimer and progressively less
important for the recruitment of PPP2R5/B9, PPP2R3/B0 and the
striatin/B90 subunits to PP2AA/C [8].
The carboxylmethylation of PP2AC on leu309 is reversed by the
protein phosphatase methyl esterase PME-1 [9], an enzyme found
to be associated with an inactive and demethylated pool of PP2AC
subunits [10]. Evidence suggests that PME-1 can displace the two
metal ions from the active site that are required for PP2AC activity,
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thereby inhibiting PP2AC activity in a demethylation-independent
manner (6). This inactive pool of PP2AC can also be reactivated by
a phosphotyrosyl phosphatase activator (PTPA) in vitro [10]. The
mechanism of PP2AC reactivation by PTPA remains undefined,
however, evidence suggests that the PTPA-mediated peptidyl-
prolyl cis/trans isomerase activity and consequent conformational
change to the structure of PP2AC seems likely [11].
Structural X-ray crystallographic studies [12–14] have shown
that the last 6 C-terminal amino acids (304TPDYFL309) of
PP2AC interact with both the active site and a unique lid domain
of LCMT-1, the latter of which may confer some degree of
substrate specificity. These 6 C-terminal amino acids of PP2AC are
highly conserved between species [15] and occupy the deep active
site pocket of LCMT-1, which is facilitated by interaction between
the catalytic sites of active PP2AC and LCMT-1, thereby
suggesting that PP2AC can only be carboxylmethylated by
LCMT-1 once in an active conformation [16]. This ensures that
only active PP2AC subunits can be carboxylmethylated and is
therefore thought to prevent uncontrolled PPP2R2/B-PP2A-
mediated dephosphorylation [16].
The importance of understanding the regulation of cellular
PP2AC activity is confirmed by the number of human diseases
such as diabetes [17], cancer [18], Alzheimer’s disease [19] and
heart failure [20,21] which appear to share (in part) a PP2A-based
aetiology. Despite this, the role and regulation of PP2AC
carboxylmethylation in cells is poorly understood. In the heart,
several studies [22–25] demonstrate that stimulation of adenosine
type 1 receptors can induce not only PP2AC carboxylmethylation
but also PP2AC translocation to the membrane-rich particulate
fraction of ventricular myocytes. Furthermore, previous work by
ourselves [23] and others [22] has shown that the phosphorylation
status of selected proteins that are expressed within the membrane-
rich particulate fraction of ventricular myocytes is reduced,
thereby altering the function of these proteins. Since type 2A
protein phosphatases represent the only identifiable LCMT-1
substrates [26], it is surprising that this important LCMT-1/PME-
1/PP2AC intracellular signalling axis has not been more exten-
sively studied in cardiac cells.
Hence, the current study investigates the intracellular signalling
mechanisms through which GiPCR stimulation regulates PP2AC
carboxylmethylation and subcellular distribution in ARVM. We
demonstrate that (i) the LCMT-1/PME-1/PP2AC/B55a intracel-
lular signalling axis is mainly localised in the cytoplasm, (ii) PP2AC
carboxylmethylation can be induced by multiple GiPCR agonists,
(iii) A1.R stimulation increases the cellular association between
PP2AC and LCMT-1 and (iv) A1.R-induced PP2AC translocation
to a membrane-rich particulate fraction occurs through a Gbc -
PI3K pathway.
Materials and Methods
Animal tissue used in this study was obtained in accordance
with the UK Home Office Guidance on the Operation of the
Animals (Scientific Procedures) Act 1986, published by Her
Majesty’s Stationery Office, London, and approved by the
Institutional Animal Care and Use Committee (IACUC) of King’s
College London. Healthy animals were sacrificed by a schedule
one procedure completed by a home office licensed individual
such that animal suffering was categorised as minimal.
Antibodies and reagents
Antibodies were from the following sources: monoclonal anti-
PP2ACa/b (05-421), monoclonal anti-methyl PP2Ac (2A10) and
monoclonal anti-demethylated PP2AC (4B7) antibodies were
purchased from Millipore/Upstate Biotechnologies, UK; poly-
clonal anti-Gat1 (K20), monoclonal anti-LCMT-1 (4A4), poly-
clonal anti-PP2AC (FL-309) and monoclonal anti-PME-1 (B12)
antibodies were purchased from Santa Cruz Biotechnology;
polyclonal anti-cardiac troponin I (cTnI), monoclonal anti-PKB
(2H10), rabbit monoclonal anti-PKB (11E7) and phosphorylated
PKB (ser473) were obtained from Cell Signaling Technology.
Polyclonal anti-GFP antibody was purchased from Clontech; anti-
B55a (PPP2R2A) polyclonal antibody was purchased from Merck
Calbiochem; HRP-conjugated donkey anti-rabbit and sheep anti-
mouse secondary antibodies were purchased from GE Healthcare,
UK. GiPCR agonists N
6-cyclopentyladenosine (CPA), carbachol
(CCH) and CGP42112 (CGP) were purchased from Sigma-
Aldrich; LY294002 was purchased from Merck Calbiochem.
Recombinant adenovirus coexpressing enhanced green fluorescent
protein (EGFP) and the Ga subunit of transducin (Gat1) was a kind
gift from Professor Thomas Wieland [27], University of Heidel-
berg, Germany.
Cell culture of adult rat ventricular myocytes
ARVM were isolated from the hearts of adult male Wistar rats
(200–250 g, B & K Universal Ltd) by collagenase-based enzymatic
digestion, as previously described [28]. The isolated myocytes were
pelleted by brief centrifugation at 50 g and washed at room
temperature with M199 culture medium (Invitrogen) containing
100 IU/ml penicillin/streptomycin and 10% FBS. Following
further centrifugation at 50 g, ARVM were resuspended in
modified M199 containing (in mM) creatine 2, carnitine 2, taurine
5, 100 IU/ml penicillin/streptomycin and 10% FBS. ARVM were
then added to 6-well cell culture plates, that had been earlier
coated with laminin as previously described [28] and allowed to
adhere for 90 minutes in an incubator (37uC, 5% CO2). The
culture medium was then replaced with fresh modified M199
medium, prior to adenoviral infection.
Adenoviral infection of adult rat ventricular myocytes
The recombinant adenovirus which co-expresses enhanced
green fluorescent protein (EGFP) with the bovine Galpha subunit
of the transducin GPCR (AdV:Gat1) was constructed using the
AdEasy system [29] and a kind gift from Professor T Wieland,
University of Heidelberg [27,30,31]. Adenovirus expressing EGFP
alone (AdV:EGFP) was used as a control. The recombinant
adenoviruses were amplified in HEK-293 cells and purified over
CsCl2 gradients as previously described [28], which produced
high-titre viral stocks of 3–56109 plaque forming units (pfu)/ml, as
determined by a serial end-point dilution assay [32]. ARVM were
infected with AdV:EGFP (control) or AdV:Gat1 at a multiplicity of
infection (MOI) of 50 pfu/ARVM (which provided .90%
transduction efficiency). The adenovirus-containing medium was
then removed after 60 min and replaced with fresh modified
M199 medium. ARVM were maintained in an incubator (37uC,
5%CO2) and were used for experiments 18 h after infection.
Stimulation of adult rat ventricular myocytes with GiPCR
agonists
ARVM were exposed to the angiotensin II type 2 receptor
agonist CGP42112 (0.01–100 nM, 10 min), the muscarinic
receptor agonist carbachol (0.01–100 mM, 10 min) or adenosine
type 1 receptor (A1.R) agonist CPA (0.01–100 mM, 10 min), to
stimulate their cognate GPCRs. Control cells received vehicle
(phosphate buffered saline or 0.1% DMSO in PBS) for an identical
period. At the end of the exposure period, ARVM were lysed with
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either Laemmli SDS-PAGE sample buffer (for immunoblotting) or
a lysis buffer for subcellular fractionation.
Immunoprecipitation of PP2ACa/b from adult rat
ventricular myocytes
ARVM were exposed to vehicle control (DMSO, 0.1%) or CPA
(10 mM) for 10 min and then lysed with ice-cold immunoprecip-
itation buffer (in mM); imidazole-HCl 20, EDTA 2, EGTA 2 and
0.1% Triton X-100. The culture plates were frozen on a volume of
liquid N2 and subsequently thawed at room temperature at which
point cellular lysates were harvested. The insoluble cellular
components were collected as a pellet following centrifugation at
14000 g for 10 min at 4uC. A 100 ml aliquot of the supernatant
was then removed and to this 50 ml of 36Laemmli sample buffer
was added, this is referred to as the ‘‘input’’. To immunopreciptate
PP2ACa/b, 100 mg of protein from the remaining supernatant was
incubated with 5 mg of immunoprecipitating antibody (mouse
monoclonal anti-PP2ACa/b) or non-immune mouse IgG (Milli-
pore, UK), overnight at 4uC. Then 50 ml of protein A sepharose
beads (GE Healthcare) was added for a further 1.5 hours at 4uC.
The beads were collected by centrifugation at 370 g for 1 min and
at 4uC. The immunocomplex was then washed twice with ice-cold
PBS and 50 ml of 26 Laemmli sample buffer was added to the
immunocomplex. All samples were then heated to 95uC for 5 min
prior to SDS-PAGE and Western immunoblotting. Equal volumes
(20 ml) of each sample were loaded per well.
Subcellular fractionation of adult rat ventricular myocytes
ARVM were fractionated using a previously described protocol
[33], with minor modifications. In brief, ARVM were lysed in ice-
cold lysis buffer at pH 7.5 containing (in mM) Tris-HCl 50, EGTA
5, EDTA 2, DTT 5, as well as 0.05% digitonin and Mini-
Complete protease inhibitor cocktail (Roche, Germany). The
samples were then frozen by floating the culture plate on a volume
of liquid N2 and subsequently thawed at room temperature, at
which point cellular lysates were harvested. Cell lysates were then
centrifuged at 14000 g for 30 min at 4uC and the supernatant,
which contained the cytoplasmic fraction, was removed. The
pellet, which contained the membrane-rich particulate fraction,
was then solubilised in an equal volume of the digitonin-based lysis
buffer containing 1% Triton X-100. The determination of total
PP2Ac content in the cytosolic and particulate subcellular fractions
was achieved by NaOH-mediated saponification of the methylated
C-terminal leu309 residue of PP2AC. In brief, an equal volume of
200 mM NaOH (100 mM final [NaOH]) was added to each
cytosolic and particulate fraction, followed by incubation for
30 min at 30uC and subsequent pH neutralisation by the addition
of 1 M HCl, as previously described [23]. This ensured that all
PP2AC protein in the sample was in a demethylated state, thereby
allowing detection of total PP2AC content by the anti-PP2AC
monoclonal antibody (4B7). Equal volumes of Laemmli SDS-
PAGE sample buffer were added to both fractions and the
fractionated proteins resolved by 12% SDS-PAGE followed by
western immunoblotting.
Western immunoblotting
Western immunoblotting was carried out as previously
described [34]. In brief, protein samples were separated by 12%
SDS-PAGE, transferred to PVDF or nitrocellulose membranes
where appropriate and probed with the primary antibodies as
described earlier. Primary antibodies were detected by appropriate
donkey anti-rabbit or sheep anti-mouse secondary antibodies
linked to horseradish peroxidase (GE Healthcare, UK). Specific
protein bands were detected by enhanced chemiluminescence (GE
Healthcare, UK) and band intensity was quantified using a
calibrated densitometer (GS-800, Bio-Rad) and Quantity OneH 1-
D analysis software (v 4.6.2).
Statistical analysis
Data are presented as mean 6 SEM. Data were subjected to
ANOVA (GraphPad Prism v6.0.1) and if a significant difference
(p,0.05) was detected, further analysis by a Dunnett’s modified t-
test (for comparison of each group with a single control) was
performed.
Results
Compartmentalisation of the PP2AC, LCMT-1 and PME-1
signalling axis in adult rat ventricular myocytes
We initially aimed to determine the subcellular localisation of
components comprising the LCMT-1/PME-1/PP2A signalling
axis in ARVM. Previous studies have demonstrated that LCMT-1
protein expression in non-myocytes is restricted to the cytoplasm,
whereas PME-1 has been shown to be predominantly expressed in
the nucleus [35]. The subcellular fractionation of ARVM by
digitonin/Triton X-100 based lysis is shown in Fig. 1 and confirms
our own previous observation [23] that the PP2AC subunit is
predominantly localised to the cytoplasmic fraction of ARVM
(Fig. 1A). Furthermore, Fig. 1A also shows that B55a (PPP2R2A)
regulatory subunit isoform that associates with the PP2AA/C
heterodimer in a methylation dependent manner [8] is similarly
localised to the cytoplasmic fraction of ARVM. Importantly, both
PME-1 (Fig. 1B) and LCMT-1 (Fig. 1C) protein expression
appears to be almost exclusively localised in the cytoplasm of
ARVM, with negligible localisation in the soluble membrane and
insoluble fractions. This suggests that all components thought to
regulate the carboxylmethylation and methylation-dependent
targeting of PP2AC to cellular substrates are predominantly
localised in the cytoplasm of ARVM.
GiPCR-induced PP2AC carboxylmethylation in adult rat
ventricular myocytes
Using an anti-methyl PP2AC antibody (2A10) to detect the
methylation status of the C-terminal leu309 of PP2AC, data shown
in Fig. 2A extends previously reported observations [22–24] that
the stimulation of Gi-protein coupled A1.Rs by N6-cylcopentyla-
denosine (CPA) induces carboxylmethylation of PP2AC, by
establishing the concentration-dependence of the response. In
addition, we provide evidence shown that the Angiotensin II type
2 receptor (AT2) agonist CGP42112 (Fig. 2B) and the muscarinic
receptor agonist carbachol (Fig. 2C) also induce PP2AC carbox-
ylmethylation in a concentration-dependent manner. Equal
protein loading was determined by using a polyclonal anti-PP2AC
(FL-309) to detect both non-methylated and methylated forms of
PP2AC. These data suggest that PP2AC carboxylmethylation can
be induced not only by the stimulation of A1.Rs but also by the
stimulation of other GiPCRs.
Using NaOH to remove the methyl moiety from the C-terminal
leu309 of PP2AC by saponification, we were able to demonstrate
that the anti-methyl PP2AC antibody (2A10) was no longer able to
detect carboxylmethylated PP2AC. Methylation of leu309 within
the TPDYFL C-terminal tail of PP2AC masks the 4B7 antibody
epitope and sterically interferes with antibody recognition of
PP2AC protein. We show in Fig. 3A that A1.R stimulation by CPA
induces an increase in PP2AC carboxylmethylation, which is
confirmed by two different antibodies raised against carboxyl-
methylated PP2AC (2A10) or demethylated PP2AC (4B7). Having
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used NaOH to remove the C-terminal (leu309) methyl moiety, the
antibody raised against demethylated PP2AC (4B7) showed an
equal amount of total PP2AC in all protein sample lanes. We
believe that this constitutes an effective protocol for the
determination of total PP2AC in any protein sample. Fig. 3B
confirms that the increased level of PP2AC carboxylmethylation in
response to either CGP42112 or carbachol is also sensitive to
saponification by NaOH.
Effects of CPA on cellular PP2AC binding partners
Several studies have shown that PP2AC can associate with
several regulatory proteins such as PME-1 [14], LCMT-1 [16] and
PKB [36] in non-myocytes. In support of this data, figure 4 shows
that PP2AC does indeed exist in association with both PME-1 and
LCMT-1 in unstimulated adult rat ventricular myocytes. Inter-
estingly the data also demonstrate that although the exposure of
ARVM to CPA does not alter the association between PP2AC and
PME-1, it increases the association between PP2AC and LCMT-1.
The data also suggest that, unlike in other cell types [36], there is
no apparent association between cellular PP2AC and PKB in adult
rat ventricular myocytes.
Role of Gbc subunits in CPA-induced PP2AC translocation
in adult rat ventricular myocytes
The classical effect of GiPCR stimulation is to induce Gai-
mediated inhibition of membrane bound adenylate cyclase [37],
however, Gbc subunits are known to mediate a range of
intracellular signalling events of their own [38]. In this study we
have exposed ARVM to increasing concentrations of CPA (0–
100 mM) for 10 minutes and determined the translocation of
PP2AC to the membrane-rich particulate fraction. Figure 5A
shows that CPA significantly (p,0.05) increased the total PP2AC
content within the particulate fraction of ARVM in a concentra-
tion dependent manner. To test the hypothesis that Gbc subunits
were mediators of the intracellular signalling cascade that led to
GiPCR-induced PP2AC translocation to the particulate fraction of
ARVM in response to GiPCR stimulation, we adenovirally
expressed the Ga subunit of the ocular transducin GPCR, Gat1
in these cells. Several studies have demonstrated that heterologous
expression of the Gat1 subunit in cells can sequester Gbc subunits
and switch off Gbc subunit-dependent intracellular signalling
[27,39,40]. Figure 5B illustrates the MOI-dependent levels of
EGFP and Gat1 protein co-expression and indicates that
considerable heterologous expression of Gat1 protein was achieved
at an MOI of 50 pfu/ARVM. Hence, ARVM were infected with
either a control EGFP-expressing or Gat1-expressing adenovirus
(each at 50 MOI) and then exposed to 10 mM CPA for
10 minutes. Figure 5C shows that CPA-induced significant
(p,0.05) PP2AC translocation to the particulate fraction in the
presence of EGFP expression. However, this translocation was
abrogated in ARVM infected to express Gat1 in order to sequester
Gbc subunits. These data suggest that CPA-induced PP2AC
translocation to the particulate fraction of ARVM is mediated by
Gbc subunits.
Figure 1. Subcellular localisation of proteins that regulate
PP2AC carboxylmethylation and targeting in ARVM. ARVM were
initially lysed with a digitonin-based buffer to separate the cytoplasm
and particulate fractions. The particulate fraction was then resuspended
with a Triton X-100 based buffer to separate the soluble membrane and
insoluble fractions by centrifugation. Samples were then analysed by
standard Western immunoblotting (IB). (A) Subcellular localisation of
PP2AC and B55a protein in the cytoplasm (CYTO), soluble membrane
(SOL) and insoluble (INSOL) fractions in ARVM. The presence of cardiac
troponin I (cTnI) protein was to confirm the purity of the insoluble
(INSOL) fraction. Subcellular localisation of PME-1 (B) and LCMT-1 (C)
protein in the whole cell lysate (WCL), cytoplasm (CYTO), soluble
membrane (SOL) and insoluble (INSOL) fractions in ARVM. All columns
represent mean optical density (OD) values 6 SEM, n = 3 individual
experiments.
doi:10.1371/journal.pone.0086234.g001
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CPA-induced activation of phosphoinositide 3-kinase
(PI3K) and redistribution of PP2AC in adult rat ventricular
myocytes
Several studies have shown that GiPCR stimulation can activate
the PI3K family of lipid/protein kinases [41–43]. To determine
that this occurs under our experimental conditions, we used PKB
(ser473) phosphorylation status as a surrogate index of PI3K
activity. CPA was found to induce significant (p,0.05) phosphor-
ylation of PKB at ser473 (Fig. 6A) and pretreatment of ARVM
with the PI3K inhibitor LY294002 (20 mM) abrogated this
response (Fig. 6B). These observations suggest that not only did
the activation of Gi-coupled A1.Rs induce the phosphorylation of
PKB (ser473), but that this occurred in a PI3K-dependent manner
in ARVM. Importantly, Fig. 6C shows that pretreatment of
ARVM with LY294002 (20 mM) abrogated CPA-induced PP2AC
translocation to the particulate fraction of ARVM, thereby
suggesting that GiPCR-induced PP2AC translocation is dependent
on PI3K activation in ARVM.
Discussion
Several studies [22–24] have previously shown that the
subcellular distribution of PP2AC is predominantly restricted to
the cytoplasm of ARVM, which we confirmed in the current
study. Furthermore, the PP2AC regulatory B subunit (PPP2R2A/
B55a) which is known to associate exclusively with carboxyl-
methylated PP2AC [8] and form targetable PP2A heterotrimers,
was also restricted to the cytoplasm of ARVM (Fig. 1A). This
confirms that both PP2AC and B55a are localised to the same
cellular compartment of ARVM. The overall cellular carbox-
ylmethylation status of PP2AC is thought to reflect the balance in
activity of LCMT-1 and PME-1 towards their common substrate
Figure 2. GiPCR-induced carboxylmethylation of PP2AC in ARVM. ARVM were exposed to the GiPCR agonists (A) CPA (0–100 mM), (B) CGP (0–
100 nM) or (C) CCH (0–100 mM) for 10 minutes. Carboxylmethylation of PP2AC (as % of vehicle control) was detected by Western immunoblotting (IB)
of the whole cell lysate with either an anti-methyl PP2AC (2A10) or an anti-PP2AC FL-309 (FL) antibody to determine equal protein loading. PP2AC
carboxylmethylation was quantified by densitometry and all columns represent mean values 6 SEM, n= 4–6 individual experiments, *p,0.05 vs 0
(control group).
doi:10.1371/journal.pone.0086234.g002
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PP2AC. X-ray crystallographic data suggest that the active sites of
PP2AC, LCMT-1 [16] and PME-1 [14] can interact with each
other to form tight PP2AC/LCMT-1 and PP2AC/PME-1
complexes, which regulate the methylation status of the C-
terminal leu309 of PP2AC. These observations are supported by
our own novel finding in ARVM, which suggest that cellular
PP2AC does indeed basally form an association with both PME-1
and LCMT-1. Assuming that the activities of PME-1 and LCMT-
1 remain constant, the increase in C-terminal leu309 PP2AC
methylation as a result of GiPCR stimulation, may be explained
either by a reduced PME-1 or an increased LCMT-1 association
with PP2AC. Our data suggests that the latter may be true as
GiPCR stimulation does not affect the association of PP2AC with
PME-1 protein. This novel observation may explain the basis by
which GiPCR stimulation induces an increase in C-terminal
leu309 carboxylmethylation of PP2AC. Interestingly, immunopre-
cipitation of PP2AC removed virtually all PP2AC protein from the
lysate (to undetectable levels) and a significant proportion of
cellular LCMT-1 protein was immunoprecipitated along with it.
Hence, the pool of cytoplasmic PP2AC in this complex may
represent a reservoir of predominantly carboxylmethylated PP2AC
subunits. Although PME-1 protein was shown to associate with
PP2AC, a significant proportion of PME-1 protein was still present
in the immunocomplex supernatant (post-immunoprecipitation)
and it is likely that the PP2AC in this complex is predominantly in
the demethylated state [9,10].
As PP2AC subunits are the only known LCMT-1/PME-1
substrates, it is possible that cytoplasmic PP2AC restricts the
localisation of LCMT-1, and to a lesser extent PME-1 protein, in
the cytoplasm. PME-1 protein in human HeLa cells contains a
functional 270KRKK273 nuclear localisation sequence (NLS),
which explains why in this cell type PME-1 protein is thought to
be predominantly localised in the nucleus together with demeth-
ylated PP2AC [35]. The human and rat PME-1 proteins are highly
(98%) homologous, however, much of the variance that exists
between these two PME-1 proteins, does so in the residues
adjacent to the NLS. Rat PME-1 protein contains the sequence
268VNKRKK273 which differs to the human PME-1 protein
sequence 268ISKRKK273. It is possible that the NLS contained
within rat PME-1 protein is in some way dysfunctional due to the
preceding valine/asparagine residues, which may partly explain
why in ARVM, PME-1 protein is predominantly found in the
cytoplasm and not the nucleus.
The carboxylmethylation and subsequent translocation of
PP2AC to the particulate fraction, in response to stimulated Gi
protein coupled A1.Rs, within ARVMs was reported several years
ago by the Hofmann laboratory [22,24,44]. In these studies, the
phosphorylation of proteins in response to isoprenaline, present in
the particulate fraction (troponin I and phospholamban), was
found to be decreased by the stimulation of A1.Rs in a
phosphatase-dependent manner. Our previous studies not only
Figure 3. Saponification of carboxylmethylated PP2AC by
alkalinisation. ARVM were exposed to the A1.R agonist CPA (0–
100 mM) for 10 minutes and PP2AC carboxylmethylation was detected
by Western immunoblotting (IB) with either an anti-methyl PP2AC
(2A10) or demethylated PP2AC (4B7) antibody before (2NaOH) or after
(+NaOH) saponification of the C-terminal leu309 methylation by
100 mM NaOH. (B) Carboxylmethylation of PP2AC in response to CGP
(10 nM), CPA (10 mM) or CCH (10 mM) as detected by Western
immunoblotting with either an anti-methyl PP2AC (2A10) or demeth-
ylated PP2AC (4B7) antibody with or without treatment with 100 mM
NaOH. Immunoblots are representative of 3 individual experiments.
doi:10.1371/journal.pone.0086234.g003
Figure 4. Effects of CPA on the association of PP2AC with
cellular binding partners. ARVM were exposed to either vehicle
(0.1% DMSO) control (0) or the A1.R agonist CPA (10 mM) for 10 minutes
followed by lysis with an immunoprecipitation buffer. PP2ACa/b was
then immunoprecipitated from the resulting ARVM lysates and the
immunocomplexes were then probed for the presence of PP2ACa/b,
PME-1, LCMT-1 and PKB by standard Western immunoblotting.
Immunoblots show the levels of the relevant proteins in the input,
PP2ACa/b immunocomplexes (IP: PP2ACa/b), non-specific immunocom-
plexes (IP: IgG) and supernatant (post-immunoprecipitation). The black
arrow denotes detection of the immunoprecipitating IgG molecules.
doi:10.1371/journal.pone.0086234.g004
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confirmed these observations, but identified an additional mem-
brane bound protein (Na+/H+ exchanger isoform-1) as a novel
PP2AC substrate and demonstrated that the translocation of
PP2AC to the particulate fraction was sensitive to pertussis toxin
[23]. Despite these studies suggesting that PP2AC can be regulated
by GiPCR stimulation, very little has been reported since
regarding the cellular mechanisms involved in the regulation of
PP2AC by inhibitory class GPCRs. A possibility that the PP2AC
translocation observed in ARVM may be A1.R-specific did exist.
Hence, in this study we also chose to use other GiPCR agonists
such as carbachol and CGP42112 to target M2.Rs and AT2.Rs,
respectively. Our data show that the stimulation of M2.Rs and
AT2.Rs also induced PP2AC carboxylmethylation in a concentra-
tion-dependent manner. The data suggests that PP2AC carbox-
ylmethylation is not a unique consequence of A1.R stimulation but
can occur downstream of other GiPCRs. To confirm that PP2AC
carboxylmethylation in ARVM following exposure to CPA,
carbachol or CGP42112 as detected by the anti-methyl PP2AC
antibody was genuine, we used NaOH to remove the methyl
moiety by saponification from the C-terminal leu309 of PP2AC
[23,45,46]. Saponification abolished the signal detected by the
anti-methyl PP2AC antibody and equalised the signal in all lanes,
as detected by the anti-demethylated (4B7) PP2AC antibody. This
confirmed that the methyl moiety on the C-terminal leu309 of
PP2AC conferred antibody epitope masking as previously reported
[23,45,46].
These novel observations led us to next investigate mechanisms
downstream of GiPCR stimulation and we focused our attention
on the role of Gbc subunits in GiPCR-induced cellular PP2AC
redistribution. We chose to sequester Gbc subunits by adenovirally
expressing the Gat1 subunit of the ocular transducin GPCR, a
protein not natively expressed in ARVM. Several studies
[27,39,47] have successfully expressed Gat1 subunits to implicate
a role for Gbc subunits in intracellular signalling events. Our data
demonstrate that heterologous expression of Gat1 subunits
abrogated GiPCR-induced PP2AC translocation to the particulate
fraction of ARVM. This is supported by studies suggesting the
existence of a GiPCR (A1.R)-Gbc signalling hub in cardiac tissue.
The stimulation of A1.Rs by chlorocyclopentyl adenosine in
murine hearts was shown to activate phospholipase C in a Gbc-
dependent manner [48]. Furthermore, the stimulation of the dual
(Gs/Gi) coupled b2-adrenoceptor (b2.AR) was reported to promote
the survival of adult mouse cardiomyocytes following exposure to
isoprenaline. In this study, the carboxyl terminus of b-adrenore-
ceptor kinase (bARK-ct) a commonly used Gbc inhibitor [49]
abrogated isoprenaline-induced PKB activation and cellular
survival, thereby implying that b2.AR/Gi-induced cardiomyocyte
survival involves Gbc subunit activation [41]. Our novel data
suggests that a proximal signalling step linking GiPCRs to the
regulation of PP2AC cellular localization is mediated by Gbc
subunits.
Evidence [41,50] suggests that Gbc subunits initiate intracellu-
lar signalling cascades via the activation of PI3K [38]. It has been
Figure 5. Role of Gbc subunits in CPA-induced PP2AC
translocation. ARVM were lysed with a digitonin-based buffer to
separate the cytoplasm and particulate fractions by centrifugation.
Samples were then saponified with NaOH to abrogate any PP2AC
carboxylmethylation. (A) Total PP2AC content in the particulate fraction
of ARVM in response to increasing concentrations of CPA (0–100 mM)
was indexed by Western immunoblotting (IB) with an anti-demethyl-
ated PP2AC antibody (4B7) following treatment with 100 mM NaOH.
Total PP2AC content in the particulate fraction was quantified by
densitometry. (B) Multiplicity of infection (MOI)-dependent co-expres-
sion of EGFP and Gat1 protein in ARVM infected with the AdV:Gat1. (C)
ARVM were infected with either the control AdV:EGFP or AdV:Gat1 for
18 hours and then exposed to10 mM CPA for 10 minutes. ARVM were
then lysed and total PP2AC content in the particulate fraction was
indexed by Western immunoblotting (IB) with an anti-demethylated
PP2AC (4B7) antibody following treatment of samples with 100 mM
NaOH. PP2AC content in the particulate fraction was quantified by
densitometry. All columns represent mean values 6 SEM, n = 4
individual experiments, *p,0.05 vs 0 (control group).
doi:10.1371/journal.pone.0086234.g005
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considered for some time that class IB PI3Ks can be activated by
Gbc dimers [51,52]. Class IB PI3Ks consist of a p110c catalytic
subunit associated with a regulatory subunit referred to as p101
[51]. The regulatory subunit p101 is central to the Gbc-mediated
activation of class IB PI3Ks [52]. Our observations with the PI3K
inhibitor LY294002 suggest that A1.R stimulation induces PP2AC
translocation to the particulate fraction via a Gbc/PI3K signalling
axis. In support of our observations, Zhu et al [41] reported that
the Gi arm of the dual Gs/Gi-coupled b2-adrenoceptor could also
activate PI3K via Gbc subunits in murine cardiomyocytes. Hence
our data suggests that A1.Rs are linked to PP2AC by a Gbc/PI3K
signalling axis.
Figure 6. Role of PI3K in CPA-induced PP2AC translocation. (A)
ARVM were exposed to the A1.R agonist CPA (0–100 mM) for
10 minutes and then lysed with SDS-PAGE Laemmli sample buffer for
the determination of PKB phosphorylation (ser473) and total PKB by
Western immunoblotting (IB). PKB (ser473) phosphorylation was
quantified by densitometry. (B) ARVM were pretreated with either
0.1% DMSO or 20 mM LY294002 for 30 minutes and then exposed to
0.1% DMSO (CTR) or 10 mM CPA for 10 minutes. PKB phosphorylation
(ser473) and total PKB were then determined by Western immunoblot-
ting (IB). PKB (ser473) phosphorylation was quantified by densitometry.
(C) ARVM were pretreated with either 0.1% DMSO or 20 mM LY294002
for 30 minutes and then exposed to 0.1% DMSO (CTR) or 10 mM CPA for
10 minutes. ARVM were then lysed with 0.05% digitonin and
fractionated by centrifugation. Samples were then saponified with
NaOH to remove any PP2AC carboxylmethylation. Total PP2AC content
in the particulate fraction of ARVM was indexed by Western
immunoblotting (IB) with anti-demethylated PP2AC (4B7) antibody
following treatment with 100 mM NaOH. Total PP2AC content in the
particulate fraction was quantified by densitometry. All columns
represent mean values 6 SEM, n = 4 individual experiments, *p,0.05
vs 0 (control group).
doi:10.1371/journal.pone.0086234.g006
Figure 7. Suggested intracellular signalling mechanism (s)
through which A1.Rs induce PP2AC translocation. Our data
suggests that the stimulation of Gi protein-coupled adenosine A1
receptors by the agonist CPA increases the association of PP2AC with
LCMT-1, thereby augmenting the leucine carboxylmethylation status of
PP2AC. The stimulation of Gi protein-coupled adenosine A1 receptors
by the agonist CPA also elicits a cascade involving the release of Gbc
subunits which activate PI3K. Both of these intracellular signalling
events coordinate and facilitate the association of PP2AC with the
membrane-rich particulate compartment of ARVM.
doi:10.1371/journal.pone.0086234.g007
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In conclusion, our data indicate that GiPCR agonists may
induce the carboxylmethylation of PP2AC by increasing its
association with the methyltransferase LCMT-1. GiPCR agonists
also mediate the disassociation of Gaibc heterotrimeric proteins
and the released Gbc subunits in turn activate PI3K. The
simultaneous activation of PI3K and induction of PP2AC
carboxylmethylation appear to coordinate the translocation of
PP2AC to the particulate fraction of ARVM in response to GiPCR
stimulation (see figure 7).
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